Our product portfolio includes orodispersable version of both generic and brand products. Our products, follow a 505 (b)2 regulatory pathway as designed by FDA. The therapeutic areas covered by our portfolio include sexual enhancement, psychotics, cardiovascular, pulmonary, pain and analgesics.
The most advanced product in our portfolio includes a sublingual formulation of sildenafil citrate. Sildenafil is registered for erectile dysfunction under the trade name of ViagraTM.
The second most advanced product in our generics pipeline is Propranolol, a generic version of the marketed drug. This product is currently the subject of a reformulation for cardiovascular and hypertension.
Following table demonstrates our current product pipeline: